Kestra Advisory Services’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $48.3K | Hold |
|
|||||
|
2022
Q4 | $29K | Sell |
|
|||||
|
2022
Q3 | $85K | Buy |
|
|||||
|
2022
Q2 | $80K | Buy |
|
|||||
|
2022
Q1 | $173K | Hold |
|
|||||
|
2021
Q4 | $213K | Hold |
|
|||||
|
2021
Q3 | $189K | Hold |
|
|||||
|
2021
Q2 | $173K | Sell |
|
|||||
|
2021
Q1 | $261K | Sell |
|
|||||
|
2020
Q4 | $238K | Buy |
|
|||||
|
2020
Q3 | $208K | Buy |
|